Published in Pharmacol Rev on December 11, 2013
Inflammasomes in neuroinflammation and changes in brain function: a focused review. Front Neurosci (2014) 1.26
Mechanisms of chemotherapy-induced behavioral toxicities. Front Neurosci (2015) 0.92
GABAergic control of depression-related brain states. Adv Pharmacol (2015) 0.86
Role of neuro-immunological factors in the pathophysiology of mood disorders. Psychopharmacology (Berl) (2016) 0.86
Psychological and psychosocial determinants of musculoskeletal pain and associated disability. Best Pract Res Clin Rheumatol (2015) 0.84
Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice. Mol Brain (2015) 0.83
Clocking in: chronobiology in rheumatoid arthritis. Nat Rev Rheumatol (2015) 0.83
Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review. Int J Mol Sci (2016) 0.81
Interleukin-6 promoter polymorphism interacts with pain and life stress influencing depression phenotypes. J Neural Transm (Vienna) (2016) 0.80
Inflammation-induced pain sensitization in men and women: does sex matter in experimental endotoxemia? Pain (2015) 0.79
Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res (2017) 0.78
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity. Int J Neuropsychopharmacol (2015) 0.77
Evidence for a distinct neuro-immune signature in rats that develop behavioural disability after nerve injury. J Neuroinflammation (2015) 0.77
Adolescent intermittent ethanol reduces serotonin expression in the adult raphe nucleus and upregulates innate immune expression that is prevented by exercise. Brain Behav Immun (2016) 0.77
Inflammation is increased with anxiety- and depression-like signs in a rat model of spinal cord injury. Brain Behav Immun (2015) 0.76
An active inference theory of allostasis and interoception in depression. Philos Trans R Soc Lond B Biol Sci (2016) 0.76
Signs of ongoing inflammation in female patients with chronic widespread pain: A multivariate, explorative, cross-sectional study of blood samples. Medicine (Baltimore) (2017) 0.76
Spared Nerve Injury Increases the Expression of Microglia M1 Markers in the Prefrontal Cortex of Rats and Provokes Depression-Like Behaviors. Front Neurosci (2017) 0.75
Depression and chronic pain in the elderly: links and management challenges. Clin Interv Aging (2017) 0.75
Lifetime Modulation of the Pain System via Neuroimmune and Neuroendocrine Interactions. Front Immunol (2017) 0.75
Clear differences in cerebrospinal fluid proteome between women with chronic widespread pain and healthy women - a multivariate explorative cross-sectional study. J Pain Res (2017) 0.75
Role of Inflammation in Human Fatigue: Relevance of Multidimensional Assessments and Potential Neuronal Mechanisms. Front Immunol (2017) 0.75
Microglia: An Interface between the Loss of Neuroplasticity and Depression. Front Cell Neurosci (2017) 0.75
Suicidality and associated risk factors in outpatients attending a general medical facility in rural Kenya. J Affect Disord (2017) 0.75
The Link between Depression and Chronic Pain: Neural Mechanisms in the Brain. Neural Plast (2017) 0.75
Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis. Front Mol Neurosci (2017) 0.75
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 58.92
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain (1988) 15.15
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry (2006) 11.84
Antidepressant effects of ketamine in depressed patients. Biol Psychiatry (2000) 10.91
DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol (2006) 10.73
An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain (1992) 9.17
The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry (2003) 7.19
Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA (1998) 6.44
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature (2011) 6.40
Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain (2000) 6.21
Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry (2001) 4.70
Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med (2001) 4.39
Algorithm for neuropathic pain treatment: an evidence based proposal. Pain (2005) 3.92
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A (2005) 3.59
DAMPening inflammation by modulating TLR signalling. Mediators Inflamm (2010) 3.29
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry (2008) 3.28
Signaling in innate immunity and inflammation. Cold Spring Harb Perspect Biol (2012) 3.11
Interactions between the immune and nervous systems in pain. Nat Med (2010) 2.91
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry (2002) 2.87
Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci (2003) 2.87
The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A (2001) 2.71
Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol (2004) 2.60
Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain (2005) 2.55
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J Neuroinflammation (2008) 2.53
Sickness behavior as a new target for drug development. Trends Pharmacol Sci (1992) 2.42
BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion. J Cell Biol (2002) 2.40
Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am (1996) 2.37
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry (2009) 2.36
Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry (2009) 2.33
Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature (2008) 2.30
The effects of tryptophan depletion on mood and psychiatric symptoms. J Affect Disord (2001) 2.28
Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J Neurosci (2009) 2.22
Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain (2009) 2.22
Comorbid depression, chronic pain, and disability in primary care. Psychosom Med (2006) 2.20
Roles of the cation-chloride cotransporters in neurological disease. Nat Clin Pract Neurol (2008) 2.19
Dorsal root potentials and dorsal root reflexes: a double-edged sword. Exp Brain Res (1999) 2.16
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
Why cancer and inflammation? Yale J Biol Med (2006) 2.13
Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology (2007) 2.12
Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J Neurosci (2003) 2.10
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol (1993) 2.08
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
Endotoxin produces a depressive-like episode in rats. Brain Res (1996) 2.04
IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol Psychiatry (2005) 1.98
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A (2011) 1.95
Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia (2005) 1.93
Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain (1995) 1.92
Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med (2008) 1.88
Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology (2000) 1.86
Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain (2000) 1.83
Characterization of cytokine-induced hyperalgesia. Brain Res (1994) 1.78
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.78
Induction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behavior. J Immunol (2009) 1.77
Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun (2004) 1.73
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci (2005) 1.73
Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sci (1989) 1.70
Cytokine-to-brain communication: a review & analysis of alternative mechanisms. Life Sci (1995) 1.68
GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol (2006) 1.66
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain (2006) 1.66
Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum (2006) 1.64
Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. Anesthesiology (2002) 1.63
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther (1991) 1.57
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol (2000) 1.57
Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J Neurosci (1999) 1.53
Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat. Eur J Neurosci (2003) 1.51
Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest (2012) 1.51
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A (1992) 1.49
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res (2006) 1.46
Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des (2005) 1.44
Spinal glutamate uptake is critical for maintaining normal sensory transmission in rat spinal cord. Pain (2005) 1.44
Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med (2007) 1.43
Reciprocal interactions between microglia and neurons: from survival to neuropathology. Rev Neurosci (2002) 1.43
NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology (2013) 1.40
Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS. Pain (2005) 1.38
Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain (2000) 1.37
Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain (1997) 1.37
The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell Mol Life Sci (2007) 1.36
Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J (1999) 1.33
Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III (1994) 1.33
Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr (2008) 1.33
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J (1996) 1.32
Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav (2000) 1.32
Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Prog Neuropsychopharmacol Biol Psychiatry (2006) 1.31
Anxiety and depression in patients with rheumatoid arthritis. Clin Rheumatol (2006) 1.31
IDO expression in the brain: a double-edged sword. J Mol Med (Berl) (2007) 1.30
Efficacy of antidepressants as analgesics: a review. J Clin Pharmacol (2011) 1.29
Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.28
Neuregulin-ErbB signaling promotes microglial proliferation and chemotaxis contributing to microgliosis and pain after peripheral nerve injury. J Neurosci (2010) 1.26
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther (2007) 1.26
Pain, depression, and fatigue in community-dwelling adults with and without a history of cancer. J Pain Symptom Manage (2006) 1.25
Ketamine for chronic pain: risks and benefits. Br J Clin Pharmacol (2014) 1.25
G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol (2005) 1.24
Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain. Behav Brain Res (2011) 1.24
Antidepressant therapy and C-reactive protein levels. Br J Psychiatry (2006) 1.24
Animal and cellular models of chronic pain. Adv Drug Deliv Rev (2003) 1.21
IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol (2005) 1.20
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry (2008) 3.28
Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry (2002) 2.87
Sickness behavior as a new target for drug development. Trends Pharmacol Sci (1992) 2.42
CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol Psychiatry (2009) 2.36
[Chronic fatigue syndrome: a psychoneuroimmunological perspective]. Tijdschr Psychiatr (2009) 2.05
Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging (2007) 2.03
A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci (2000) 1.93
Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. Brain Res Mol Brain Res (1994) 1.90
A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci U S A (1999) 1.90
Interleukin-10 in the brain. Crit Rev Immunol (2001) 1.89
Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res (2005) 1.88
Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J (1999) 1.83
Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol (2000) 1.57
Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berl) (1987) 1.49
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A (1992) 1.49
Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. Eur J Neurosci (2000) 1.43
Cytokine signals propagate through the brain. Mol Psychiatry (2000) 1.42
Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37
Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res (1992) 1.37
Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology (2001) 1.37
The enzyme indoleamine 2,3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain Behav Immun (2002) 1.35
Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiol Aging (2006) 1.33
Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III (1994) 1.33
Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. FASEB J (1999) 1.33
IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3'-kinase. J Immunol (2001) 1.33
Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol (2000) 1.33
Role of IL-6 in cytokine-induced sickness behavior: a study with IL-6 deficient mice. Physiol Behav (2000) 1.32
Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology (1994) 1.31
Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience (1999) 1.31
Subdiaphragmatic vagotomy blocks induction of IL-1 beta mRNA in mice brain in response to peripheral LPS. Am J Physiol (1995) 1.29
Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology (1999) 1.28
The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci (2000) 1.23
Gonadal steroids influence the involvement of arginine vasopressin in social recognition in mice. Psychoneuroendocrinology (1993) 1.22
Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity. J Infect Dis (2001) 1.20
Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosom Med (2001) 1.20
Localization of human antigen-specific helper and suppressor function in distinct T-cell subpopulations. Cell Immunol (1979) 1.19
Differential effects of lipopolysaccharide on pup retrieving and nest building in lactating mice. Brain Behav Immun (1997) 1.17
Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology (2007) 1.17
Regulation of B cell activity in man: role of T cells. Immunol Rev (1979) 1.17
Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol (1999) 1.14
Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun (1995) 1.13
Social recognition does not involve vasopressinergic neurotransmission in female rats. Brain Res (1990) 1.13
Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci (2008) 1.12
Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol (2001) 1.12
Androgen-dependent vasopressinergic neurons are involved in social recognition in rats. Brain Res (1990) 1.11
Beta 2-adrenergic activation enhances interleukin-8 production by human monocytes. J Neuroimmunol (1997) 1.10
Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes. Neuroreport (1996) 1.09
Cardiovascular and endocrine responses to experimental stress: effects of mental effort and controllability. Psychoneuroendocrinology (1998) 1.08
Immunoregulatory T cell subpopulations in man: dissection by monoclonal antibodies and Fc-receptors. Immunol Rev (1983) 1.08
Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. Am J Respir Crit Care Med (2000) 1.05
Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res (1991) 1.04
Attentional and mnemonic deficits associated with infectious disease in humans. Psychol Med (1999) 1.04
Stress in farm animals: a need for reevaluation. J Anim Sci (1983) 1.04
Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun (1995) 1.04
Centrally injected arginine vasopressin (AVP) facilitates social memory in rats. Neurosci Lett (1987) 1.03
Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for alpha(1)-adrenergic receptors. J Neuroimmunol (2000) 1.02
Influence of life stress on immunological reactivity to mild psychological stress. Psychosom Med (1994) 1.02
Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Mol Psychiatry (2007) 1.02
Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis. J Infect Dis (2000) 1.02
Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J Clin Invest (1992) 1.01
Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. Eur Cytokine Netw (1998) 1.01
Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res (1997) 1.01
Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children. Eur J Pediatr (1999) 1.01
Interleukin-1 mediates behavioural but not metabolic effects of tumor necrosis factor alpha in mice. Eur J Pharmacol (1991) 1.01
Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod (2009) 1.00
Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci Biobehav Rev (1996) 0.99
Adrenalectomy enhances pro-inflammatory cytokines gene expression, in the spleen, pituitary and brain of mice in response to lipopolysaccharide. Brain Res Mol Brain Res (1996) 0.98
Vagotomy attenuates behavioural effects of interleukin-1 injected peripherally but not centrally. Neuroreport (1996) 0.98
Altered immune function in human newborns after prenatal administration of betamethasone: enhanced natural killer cell activity and decreased T cell proliferation in cord blood. Pediatr Res (1999) 0.98
Central and peripheral prostaglandins are involved in sickness behavior in birds. Physiol Behav (1993) 0.98
In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology (1998) 0.97
Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats. Brain Res (1995) 0.97
Short- and long-term effects of neonatal glucocorticoid therapy: is hydrocortisone an alternative to dexamethasone? Acta Paediatr (2003) 0.97
Social and individual recognition in rodents: Methodological aspects and neurobiological bases. Behav Processes (2002) 0.97
Role of interferon-gamma in counteracting the suppressive effects of transforming growth factor-beta 2 and glucocorticoids on the production of tumor necrosis factor-alpha. J Leukoc Biol (1990) 0.97
Characterization of human T suppressor-inducer, -precursor and -effector lymphocytes in the antigen-specific plaque-forming cell response. Eur J Immunol (1982) 0.97
The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc Natl Acad Sci U S A (1991) 0.97
T-T interactions in the induction of antigen-specific human suppressor T lymphocytes in vitro. J Immunol (1979) 0.97
Cerebral and hepatic inflammatory response after neonatal hypoxia-ischemia in newborn rats. Dev Neurosci (2013) 0.97
C3H/HeJ mice are refractory to lipopolysaccharide in the brain. Brain Res (1997) 0.96
Diffusion and action of intracerebroventricularly injected interleukin-1 in the CNS. Neuroscience (2000) 0.96
Activation of protein kinase C-zeta and phosphatidylinositol 3'-kinase and promotion of macrophage differentiation by insulin-like growth factor-I. J Immunol (1998) 0.95
Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. J Neuroimmunol (1999) 0.95
Effect of floor area restriction upon performance, behavior and physiology of growing-finishing pigs. J Anim Sci (1987) 0.95
Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. Physiol Behav (1994) 0.94
Noradrenaline induces phosphorylation of ERK-2 in human peripheral blood mononuclear cells after induction of alpha(1)-adrenergic receptors. J Neuroimmunol (2000) 0.94
Chronic treatment with the atypical antidepressant tianeptine attenuates sickness behavior induced by peripheral but not central lipopolysaccharide and interleukin-1beta in the rat. Psychopharmacology (Berl) (2001) 0.94
The role of IL-1 in the corticotropin-releasing factor and arginine- vasopressin-induced secretion of immunoreactive beta-endorphin by human peripheral blood mononuclear cells. J Immunol (1989) 0.94